Innovative Diabetes Care and Education Services to Improve Outcomes in Youth-Onset Type 2 Diabetes

Abstract

Get full access to this article

View all access options for this article.

References

Wagenknecht

Lawrence

Isom

, et al. Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study. Lancet Diabetes Endocrinol. 2023;11(4):242-250. doi:10.1016/S2213-8587(23)00025-6

Imperatore

Boyle

Thompson

, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35(12):2515-2520. doi:10.2337/dc12-0669

Shah

Barrientos-Pérez

Chang

, et al. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024;97(6):555-583. doi:10.1159/000543033

Nadeau

Mayer-Davis

Gubitosi-Klug

, et al. Youth-onset type 2 diabetes: what we’ve learned from key youth-onset type 2 diabetes studies, what we still don’t know, and why it is important. Diabetes Care 2025;48(7):1136-1149. doi:10.2337/dc25-0001

Arslanian

Bacha

Grey

Marcus

White

Zeitler

Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Diabetes Care. 2018;41(12):2648-2668. doi:10.2337/dci18-0052

American Diabetes Association Professional Practice Committee. 14. Children and adolescents: standards of care in diabetes—2025. Diabetes Care. 2025;48(suppl 1):S283-S305. doi:10.2337/dc25-S014

Venditti

Tan

Chang

, et al. Barriers and strategies for oral medication adherence among children and adolescents with type 2 diabetes. Diabetes Res Clin Pract. 2018;139:24-31. doi:10.1016/j.diabres.2018.02.001

Shah

McKay

Levitt Katz

, et al. Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medication. J Pediatr Endocrinol Metab. 2020;33(2):191-198. doi:10.1515/jpem-2019-0315

Weinstock

Trief

Burke

, et al. Antihypertensive and lipid-lowering medication adherence in young adults with youth-onset type 2 diabetes. JAMA Netw Open. 2023;6(10):e2336964. doi:10.1001/jamanetworkopen.2023.36964

10.

Ryan

Burke

Litchman

, et al. Competencies for diabetes care and education specialists. Diabetes Educ. 2020;46(4):384-397. doi:10.1177/0145721720931092

11.

Gorgojo-Martínez

Mezquita-Raya

Carretero-Gómez

, et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2022;12(1):145. doi:10.3390/jcm12010145

12.

Association of Diabetes Care and Education Specialists; Kolb

. An effective model of diabetes care and education: the ADCES7 Self-Care Behaviors™. Sci Diabetes Self Manag Care. 2021;47(1):30-53. doi:10.1177/0145721720978154